A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: 5-fluorouracil|DRUG: Epidoxorubicin|DRUG: Cyclophosphamide|DRUG: Paclitaxel|BIOLOGICAL: Bevacizumab
Sponsor: Hoffmann-La Roche